{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Medsider: Learn from Medtech and Healthtech Founders and CEOs","title":"Why Intersect ENT is an Example of Hope for the Medtech Industry","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/bff72a32\"></iframe>","width":"100%","height":180,"duration":2251,"description":"The 2.3% medical device tax is burdensome. Regulatory timelines are long (and expensive). Reimbursement is not only decreasing, but also incredibly hard to obtain. Venture capitalists are losing interest in early stage medical device deals. Is it all downhill for medtech? There is no doubt the current healthcare environment is challenging. But certainly not impossible...[read more]\nRelated Articles\nAre Medical Device Models the Key to Building a Lean Medtech Startup?\nWhy Early Stage Medical Device Deals Aren’t as Bad as You May Think\nSubstantial and Sustainable – 2 Words That Medtech Companies Should Get Used To ","thumbnail_url":"https://img.transistorcdn.com/GgkwQ6SZM6b2rlIWqV8q-HUOooXOpwR2mZVZnhA1EYA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzM2MTYwLzE2OTUx/MzY5NjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}